Prostate-specific antigen (PSA)-mediated proliferation, androgenic regulation and inhibitory effects of LY312340 in HOS-TE85 (TE85) human osteosarcoma cells

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2725-2732

  Gygi, Christian M ^b   Leibovitch, Ilan Y ^b   Adlington, Robert ^c   Baldwin, Jack E ^c   Chen, Beining ^c   McCoull, William ^c   Pritchard, Gareth J ^c   Becker, Gerald W ^a   Dixon, Eric P ^a   Little, Sheila P ^a   Sutkowski, Debra M ^a   Teater, Carroll ^a   Neubauer, Blake Lee ^a  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bone metastasis; Growth factor; LY312340; Mono cyclic lactam; Prostatic cancer; PSA inhibitor; Reverse transcriptase polymerase chain reaction; Serine protease

Indexed keywords

BETA LACTAM DERIVATIVE; LY 312340; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HORMONAL REGULATION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL;

ADOLESCENT; BENZOIC ACIDS; BONE NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; LACTAMS; NEOPLASMS, HORMONE-DEPENDENT; OSTEOSARCOMA; PROSTATE-SPECIFIC ANTIGEN; TESTOSTERONE; TUMOR CELLS, CULTURED;

EID: 0036765808     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Wingo PA, Tong T and Bolden S: Cancer statistics, 1995 [published erratum appears in CA Cancer J Clin 1995 Mar-Apr; 45(2): 127-8], Ca: a Cancer Journal for Clinicians 45: 8-30, 1995.
2. Gaddipati J, Ahmed T and Friedland M: Prostatic and bladder cancer in the elderly, clinics in geriatric medicine 3: 649-67, 1987.
3. Chiarodo A: National Cancer Institute roundtable on prostate cancer: Future research directions. Cancer Res 51: 2498-505, 1991.
4. Ban Y, Wang MC, Watt KWK, Loor R and Chu TM: The proteolytic activity of human specific antigen. Bioch Bioph Res Comm 123: 482-488, 1984.
5. Lilja H: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 76: 1899-1903, 1985.
6. Lilja H, Oldbring J, Rannevik G and Laurell CB: Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 80: 281-285, 1987.
7. Graves HCB, Kamarei M and TAS: Identity of prostate specific Aantigen (PSA) and the semen protein P30 purified by a rapid chromatography technique. J Urol 144: 1510-1515, 1990.
8. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC and Rosenfeld RG: Prostate specific antigen (PSA) is an insulin-like growth factor binding protein - 3 protease found in seminal plasma. J Clin Endoc Metab 75: 1046-1053, 1992.
9. Sutkowski DM, Baniel J, Goode RL, McNulty AM, Becker GW and Neubauer BL: Growth regulation of primary cultures of human prostatic stromal cells by prostate specific antigen (PSA). J Nat Cancer Inst 91: 1663-1668, 1999.
10. Webber MM, Waghray A and Bello D: Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1: 1089, 1995.
11. Haq M, Goltzman D, Tremblay G and Brodt P: Rat Prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res 52: 4613-9, 1992.
12. Koutsilieris M, Rabbani SA, Bennett HP and Goltzman D: Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. J Clin Investigation 80: 941-6, 1987.
13. Perkel VS, Mohan S, Baylink DJ and Linkhart TA: An inhibitory insulin-like growth factor binding protein (IGFBP) from human prostatic cell conditioned medium reveals N-terminal identity with bone derived IGFBP. J Clin Endoc Metab 71: 533-535, 1990.
14. Adlington RM, Baldwin JE, Becker GW, Cooper SL, Hermann RB, Howe TJ, McCoull W, McNulty AM, Neubauer BL and Pritchard GJ: Design and synthesis of novel monocyclic β-lactam inhibitors of prostate-specific antigen. Bioorg Med Chem Lett 7: 1689-1694, 1997.
15. Baniel J, Adlington RM, Becker GW, Goode RL, Leibovitch IYWM McNulty AM, Sutkowski DM and Neubauer BL: Prostate-specific antigen (PSA)-mediated stimulation of DU-145 human prostatic cancer (PCa) cells and inhibition of this response by LY312340, an inhibitor of PSA serine protease activity. In: Proc Amer Assoc Cancer Res 1998, pp. 430 (Abstract).
16. McAllister RM, Gardner MBAEG, Bradt C, Nichols WW and Landing BH: Cultivation in vitro of cells derived from a human osteosarcoma. Cancer 27: 397-402, 1971.
17. Benz DJ, Haussler MR, Thomas MA, Speelman B and Komm BS: High-affinity androgen binding and androgenic regulation of alpha 1(I)-procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 128: 2723-30, 1991.
18. Lehman A, Sall J and Latour K: Regression and Curve Fitting, Cary, N.C.: SAS Institute pp. 243-262, 1989.
19. Simple Logistic Regression. JMPTM Version 3 User's Guide, 2 edition, Vol. 3, Cary, NC: SAS Institute Inc pp. 111-136, 1994.
20. One-Way Layout. JMP Version 3 User's Guide, 3 edition, Cary, NC: SAS Institute Inc pp. 65-93, 1994.
21. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-16, 1987.
22. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges [see comments]. JAMA 270: 860-4, 1993.
23. Yu H, Diamandis EP, Levesque M, Asa SL, Monne M and Croce CM: Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Res 55: 1603-6, 1995.
24. Yu H and Diamandi EP: Prostate-specific antigen immunoreactivity in amniotic fluid. Clinical Chemistry 41: 204-10, 1995.
25. Yu H and Diamandis EP: Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J Urology 153: 1004-8, 1995.
26. Yu H and Diamandis EP: Prostate-specific antigen in milk of lactating women [see comments]. Clinical Chem 41: 54-8, 1995.
27. van Krieken J: Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunocytochemistry [see comments]. Am J Surg Pathol 17: 410-414, 1993.
28. Levesque M, Hu H, D'Costa M and Diamandis EP: Prostate-specific antigen expression by various tumors. Journal of Clinical Laboratory Analysis 9: 123-8, 1995.
29. Clements J and Mukhtar A: Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J Clin Endocrinol Metabolism 78: 1536-9, 1994.
30. Bilgrami S, Singh NT, Shafi N and Ciesielski T: Raised prostate-specific antigen in adenocarcinoma of lung [letter] [see comments]. Lancet 344: 1371-2, 1994.
31. Diamandis EP, Yu H and Sutherland DJ: Detection of prostate-specific antigen immunoreactivity in breast tumors, Breast Cancer Res Treatment 32: 301-10, 1994.
32. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJ, Levesque MA, Roagna R, Ponzone R and Sismondi P: Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-10, 1995.
33. Lai LC, Erbas H, Lennard TW and Peaston RT: Prostate-specific antigen in breast cyst fluid: possible role of prostate -specific antigen in hormone-dependent breast cancer. Int J Cancer 66: 743-6, 1996.
34. Conover CA, Lee PD, Riggs BL and Powell DR: Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology 137: 3295-301, 1996.
35. Mohan S and Baylink DJ: Bone growth factors. Clinical Orthopaedics & Related Res 30-48, 1991.
36. Byrne RL, Leung H and Neal DE: Peptide growth factors in the prostate as mediators of stromal epithelial interaction. British Journal of Urology 77: 627-33, 1996.
37. Cohen P, Peehl DM, Graves HC and Rosenfeld RG: Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 142: 407-15, 1994.
38. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT and Baylink DJ: Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124: 1576-8, 1989.
39. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS and Kozlowski JM: Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 126: 2534-2540, 1995.
40. Young CYF, Montgomery BT, Andrews PE, Qui S, Bilhartz BL and Tindall DJ: Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 53: 3738-3752, 1991.
41. Siebert PD: Quantitative RT-PCR. Methods and Applications, Vol. 3, Palo Alto, CA: Clontech Laboratories, 1993.
42. Cohen P, Peehl DM and Rosenfeld RG: The IGF axis in the prostate. Hormone & Metabolic Res 26: 81-4, 1994.
43. Amarnani S, Merriman HL, Linkhart TA, Baylink DJ and Mohan S: Autocrine regulators of MC3T3-E1 cell proliferation. J Bone Mineral Res 8: 157-65, 1993.
44. Baylink DJ, Finkelman RD and Mohan S: Growth factors to stimulate bone, formation. J Bone Mineral Res 8: S565-72, 1993.
45. Mohan S, Bautista CM, Herring SJ, Linkhart TA and Baylink DJ: Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium. Endocrinology 126: 2534-42, 1990.
46. Mohan S and Baylink DJ: Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system. Growth Regulation 1: 110-8, 1991.
47. Mohan S and Baylink DJ: Characterization of the IGF regulatory system in bone. Advances in Experimental Medicine & Biology 343: 397-406, 1993.
48. McCarthy TL and Centrella M: Regulation of IGF activity in bone. Adv Exp Med Biol 343: 407-414, 1993.
49. Mohan S: Insulin-like growth factor binding proteins in bone cell regulation. Growth Regulation 3: 67-70, 1993.